In this sense, the NFκB must participate in the pro-resolving pathways induced by CPC treatment because, in the OVA-induced asthma model, there is a similar pattern of COX2, NOS2, and MPO expression, as well as the reduction of proinflammatory cytokines. Here, NFKB1 is linked to asthma.